BM-derived pro-angiogenic cells are targets for Shh derived from the pancreatic tumors. Hh blockade disrupts tumor angiogenesis mediated through the impaired interaction BMDC with the neovasculature. Responsible for VEGF-independent neovascularization in pancreatic cancer. This evidence concerns the gene VEGFA and pancreatic neoplasm.